Navigation Links
Isis' Partners Present Clinical Data on Antisense Drugs at the American Society of Clinical Oncology
Date:6/2/2008

CHICAGO and CARLSBAD, Calif., June 2 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced today that two of the Company's partnered oncology drugs were highlighted during the American Society of Clinical Oncology (ASCO) meeting. Data from both drugs highlighted positive activity that supports the continuation of clinical development, and both drugs were well tolerated up to very high doses. Results from Eli Lilly's Phase 1 clinical trial evaluating LY2181308 in patients with cancer and updated data from OncoGenex's Phase 2 trial evaluating OGX-011 in patients with hormone refractory prostate cancer (HRPC) were presented yesterday, June 1, at the annual ASCO meeting in Chicago. Both Lilly and OncoGenex are developing additional anticancer drugs discovered by Isis.

In both presentations, antisense drugs being developed by Isis' partners OncoGenex and Lilly continue to demonstrate the potential of antisense technology to treat multiple cancers. OncoGenex presented Phase 2 data on OGX-011 demonstrating better than expected survival results in combination with chemotherapy, reduction in levels of clusterin (the target of OGX-011), durable reductions in pain, and a decline in PSA, a protein that is often elevated in patients with prostate cancer. Encouraging data from this trial support initiation of registration trials required for product approval. OGX-011 was jointly discovered and is being co-developed by Isis and OncoGenex. Lilly presented first-in-human data from LY2181308 that showed the drug distributed to tumor cells with evidence of reduced survivin protein levels in tumor cells, LY2181308's target and one of the most commonly elevated proteins in cancer. Lilly has selected a dose of 750 mg/week of LY21
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
2. Briefing on a new Web resource to address global drinking water crisis
3. St. Petersburg: Candlelight Vigil to Raise Awareness of Florida HIV/AIDS Crisis, Honor Lives Lost
4. Isis Acquires Symphony GenIsis
5. New Denver Area Program Developed For Teens in Crisis
6. Isis Announces HSR Approval and Closure of Its Collaboration With Ortho-McNeil, Inc.
7. March of Dimes NICU Family Support(R) Programs Give Wisconsin Families Comfort and Information during a Crisis
8. March of Dimes NICU Family Support(R) Programs Give Florida Families Comfort and Information During a Crisis
9. Isis Reports That ISIS 301012 is Well Tolerated in Patients Treated for Five Or More Months
10. Isis Favorably Revises Financial Guidance and Introduces Mipomersen as Generic Name for ISIS 301012
11. Survey of Iowa Voters Reveals Surprising Results and Attitudes Toward Americas Health Care Crisis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... California (PRWEB) May 19, 2013 According to ... Body Firmers” many people are self-conscious about the appearance of ... an option when diet and exercise fail to tone and ... may appeal to those looking to get the firmest ... is an effective mini-overview,” says Dr. Simon Ourian, Medical Director ...
(Date:5/19/2013)... St. Louis, MO (PRWEB) May 19, 2013 ... Member Conference, May 19-22, 2013, at the Walt Disney ... the latest trends in supply chain innovation, care delivery ... a much different dynamic in all healthcare markets, ... necessary part of the conversation,” said Todd Ebert, Amerinet ...
(Date:5/19/2013)... Omaha, Nebraska is a city of diversity, economic growth ... the lowest unemployment rates in the country. Forbes Magazine distinguished ... Business and Careers and it consistently scores high on many ... in the nation and is a strong business leader thanks ... Editions TV are pleased to announce air dates ...
(Date:5/19/2013)... in Minnesota have a great option to get in shape ... Fat Loss Formula. The best part is people can ... The product sells for $135 dollars and is an immediate ... http://altmanfitness.com/28-day-fat-loss-formula/ , “Bikini season is almost here. People may ... the 28 Day Fat Loss Formula they will be happy ...
(Date:5/19/2013)... 2013 In partnership with the medical practice ... the launch of an SEO website for dentists. The purpose ... in Google. , http://www.e-dentists.com/ , A perk to ... service until they see results. Dentists can request the keywords ... run by JD Media Surge, LLC rank high for competitive ...
Breaking Medicine News(10 mins):Health News:Body Firming – The Hottest Treatments Available 2Health News:Healthcare Leaders Gather at 2013 Amerinet Member Conference to Share New Ways to Reduce Costs and Enhance Care Delivery 2Health News:Editions TV Announces May Air Dates for Omaha, Nebraska 2Health News:Effective New Dental SEO Solution Launched by E-dentists.com in Partnership with JD Media Surge, LLC 2
... According to a new federal report, in spite of the ... several new programs to overcome it//, the efficacy of these ... efforts need national leadership, according to the report, Progress in ... Institute of Medicine. This report was released yesterday. ...
... revealed that there is a “crisis” over lack of donors at ... clinics being totally out of stock//, women and couples wanting to ... the highest number of donors was 459. Ever since, the number ... law was passed that gave kids the right to know the ...
... week the distribution of a drug to help fight an ... is being affected by an extremely virulent strain of tuberculosis, ... the country. The health officials have now promised that they ... week to help fight the disease. The officials but also ...
... for an extensive study for the evaluation of the possible ... stents. // ,Stents are widely used heart devices ... had essentially eliminated short-term restenosis as a complication of coronary ... cloud for possible late-term risks. Reports indicate that almost 6 ...
... unique way to curb binge drinking, researchers say parents should allow ... youngsters // to drink at parties and at home may be ... ,Professor Mark Bellis, the author of the report said that children ... and allowed to drink with them were sensible in their approach ...
... a safe way to monitor the fate of transplanted ... issue of the journal Diabetes. // Researchers from the ... (MGH) said that they were able to track transplanted ... human transplants. ,"Clinical trials and animal studies ...
Cached Medicine News:Health News:Slow Fight Against Childhood Obesity 2Health News:Slow Fight Against Childhood Obesity 3Health News:Shortage of donors at sperm bank clinics 2Health News:South Africa To Make Available Two New Drugs To Fight The TB Outbreak 2Health News:MRI Can Monitor Transplanted Islets 2
(Date:5/17/2013)... Rico , May 17, 2013  Serving a region ... Puerto Rico , Caribbean Imaging and Radiation Therapy (CIRT, ... radiation therapy capabilities with the acquisition of an Elekta Versa ... . Versa HD offers clinicians the versatility to deliver conventional ... body, while also enabling treatment of highly complex cancers that ...
(Date:5/17/2013)... PARIS , May 17, 2013  Sanofi (EURONEXT: ... the pivotal study, JAKARTA , examining ... its primary endpoint in both dose groups. The primary ... of spleen volume. Consistent with data reported in previous ... nausea and vomiting. Full results will be presented at ...
(Date:5/16/2013)... NORTH CHICAGO, Ill. and MECHELEN, ... NV (Euronext: GLPG) and AbbVie (NYSE: ABBV ... development collaboration to include Crohn,s disease.  Galapagos will fund ... which is designed to facilitate rapid progression into Phase ... Q2 2015, AbbVie will pay Galapagos $50 million.  The ...
Breaking Medicine Technology:Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6
... , NEW YORK , July 20 ... the Susquehanna International Group of Companies (SIG), announced today that ... Senior Analyst covering the Specialty Pharmaceuticals sector. Mr. Nachman, whose ... Labs , King Pharmaceuticals, Shire Pharmaceuticals and Warner Chilcott ...
... July 20 Medical Device Consultants, Inc. ... (CRO) serving the medical device and diagnostics industry, today ... Services Ltd (CDSS), a clinical services and CRO based ... clients access to the best of both organizations, core ...
Cached Medicine Technology:Susquehanna Financial Group Hires Gary Nachman as Senior Analyst to Cover the Specialty Pharmaceuticals Sector 2Susquehanna Financial Group Hires Gary Nachman as Senior Analyst to Cover the Specialty Pharmaceuticals Sector 3Medical Device Consultants, Inc. and Clinical Development & Support Services Ltd Announce Strategic Partnership 2Medical Device Consultants, Inc. and Clinical Development & Support Services Ltd Announce Strategic Partnership 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: